Opinion: Medicare drug pricing rules will delay access to drugs … Study: JAK inhibitors linked to lower age-related macular degeneration risk … This is how sleep affects dementia risk … Geriatric...
Amazon expands mail-order subscriptions to Prime members on Medicare
By
Kristen Fischer
Jun 19, 2024
Amazon.com is letting Prime members on Medicare join its RxPass mail-order prescription service for just $5 a month. The move could save older adults more money on out-of-pocket costs for generic prescription...
Is Mom late on bills? Could be sign of dementia, report finds
By
Kristen Fischer
Jun 05, 2024
Older adults who fall behind on paying their bills may have early signs of dementia and be susceptible to further financial risks, according to a recent report.
Sticking to the plan of care pays off
By
Renee Kinder
Jun 06, 2024
Raising children, like providing patient care, requires a plan. The older our children become, like when patients show progress, the more freedom they should be allowed. The guide book for plan of care...
‘Plateaued’ is not a medical description
By
Jean Wendland Porter
May 28, 2024
I’m starting to sound like a broken record (vinyl is coming back; the kids know what I mean), but I recently heard a therapist say the patient’s progress plateaued, so we have to stop therapy. Again. ...
Report: Changes to Medicare, Medicaid could block healthcare access, lead to more deaths
By
Kristen Fischer
Apr 24, 2024
Raising the age of Medicare eligibility, among other proposed changes to Medicare and Medicaid, could cause more deaths, according to a research article published this week in the Proceedings of the National...
Financial incentives failing to fuel in-home dialysis
By
Diane Eastabrook
Oct 12, 2022
Efforts to increase in-home dialysis in the United States are falling flat, despite financial incentives to encourage the model, researchers report.
Medicare costs could soar with availability of new obesity drugs, experts say
By
Alicia Lasek
Mar 15, 2023
If efforts are successful to expand Medicare Part D to cover these drugs, premiums could soar, according to economists with Vanderbilt University and the University of Chicago.
Private equity in the crosshairs: Administration continues to question role of private equity in LTC
By
Tom Barnard
Alison Schurick
Kathleen R. Salsbury
Sabrina Marquez
Mar 13, 2023
Over the past year, the Biden administration has expressed serious doubts about the developing role of private equity investment in the long-term care industry. In a Fact Sheet released in late February...
With little to show for past efforts, SNFs under the microscope again on readmissions
By
Joe Bush
Oct 27, 2022
A federal watchdog’s announcement this week that it plans to more closely scrutinize “possibly preventable” readmissions of skilled nursing patients to hospitals underscores the federal government’s...